Synthesis, characterization, and evaluation of antimicrobial and cytotoxic effect of silver and titanium nanoparticles

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 6, Issue 5, 2010, Pages 681-688

  Martinez Gutierrez, Fidel ^a   Olive, Peggy L ^b   Banuelos, Adriana ^b   Orrantia, Erasmo ^c   Nino, Nereyda ^d   Sanchez, Elpidio Morales ^d   Ruiz, Facundo ^d   Bach, Horacio ^e   Av Gay, Yossef ^e  

^a Facultad de Ciencias Químicas   (Canada)

^b BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^c Centro de Investigaciones de Materiales Avanzados   (Mexico)

^d UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Antimicrobial activity; DNA damage; Nanoparticle toxicity; Silver nanoparticles; Titanium nanoparticles

Indexed keywords

ANTI-MICROBIAL ACTIVITY; DNA DAMAGE; NANOPARTICLE TOXICITY; SILVER NANOPARTICLES; TITANIUM NANOPARTICLES;

BIOMEDICAL ENGINEERING; CELL CULTURE; CYTOTOXICITY; DNA; GENES; MICROORGANISMS; NANOPARTICLES; TITANIUM;

SILVER;

AMIKACIN; AMPHOTERICIN B; GENTAMICIN; NANOPARTICLE; RIFAMPICIN; SILVER NANOPARTICLE; TITANIUM NANOPARTICLE; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DEVICE INFECTION; DNA DAMAGE; DRUG SCREENING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; MONOCYTE; NONHUMAN;

ANTI-INFECTIVE AGENTS; BACTERIA; CELL LINE; DNA DAMAGE; FUNGI; HUMANS; METAL NANOPARTICLES; MICROBIAL SENSITIVITY TESTS; SILVER; TITANIUM;

EID: 77955591988     PISSN: 15499634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nano.2010.02.001     Document Type: Article

References (33)

1. Kim J.S., Kuk E., Yu K.N., Kim J.H., Park S.J., Lee H.J., et al. Antimicrobial effects of silver nanoparticles. Nanomed Nanotechnol Biol Med. 2007, 3:95-101.
2. Wang P. Nanoscale biocatalyst systems. Curr Opinion Biotechnol 2006, 17:574-579.
3. Zhang L., Gu F.X., Chan J.M., Wang A.Z., Langer R.S., Farokhzad O.C. Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther 2008, 83:761-769.
4. Hong B., Kai J., Ren Y., Han J., Zou Z., Ahn C.H., et al. Highly sensitive rapid, reliable, and automatic cardiovascular disease diagnosis with nanoparticle fluorescence enhancer and MEMS. Adv Exp Med Biol 2008, 614:265-273.
5. Chau C.F., Wu S.H., Yen G.C. The development of regulations for food nanotechnology. Trends in Food Sci Technol 2007, 18:269-280.
6. Vigneshwaran N., Kathe A.A., Varadarajan P.V., Nachane R.P., Balasubramanya R.H. Functional finishing of cotton fabrics using silver nanoparticles. J Nanosci Nanotechnol 2007, 7:1893-1897.
7. Conlon J.M., Kolodziejek J., Nowotny N. Antimicrobial peptides from ranid frogs: taxonomic and phylogenetic markers and a potential source of new therapeutic agents. Biochim Biophys Acta 2004, 1696:1-14.
8. Paddle-Ledinek J.E., Nasa Z., Cleland H.J. Effect of different wound dressings on cell viability and proliferation. Plastic Reconstruct Surg 2006, 117:110S-118S.
9. Ulkur E., Oncul O., Karagoz H., Yeniz E., Celikoz B. Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigrass), and fusidic acid 2% (Fucidin) for topical antibacterial effect in methicillin-resistant Staphylococci-contaminated, full-skin thickness rat burn wounds. Burns 2005, 31:874-877.
10. Samuel U., Guggenbichler J.P. Prevention of catheter-related infections: the potential of a new nano-silver impregnated catheter. Int J Antimicrob Agents 2004, 23(Suppl 1):S75-S78.
11. Gosheger G., Hardes J., Ahrens H., Streitburger A., Buerger H., Erren M., et al. Silver-coated megaendoprostheses in a rabbit model-an analysis of the infection rate and toxicological side effects. Biomaterials 2004, 25:5547-5556.
12. Nomiya K., Yoshizawa A., Tsukagoshi K., Kasuga N.C., Hirakawa S., Watanabe J. Synthesis and structural characterization of silver(I), aluminium(III) and cobalt(II) complexes with 4-isopropyltropolone (hinokitiol) showing noteworthy biological activities. Action of silver(I)-oxygen bonding complexes on the antimicrobial activities. J Inorg Biochem 2004, 98:46-60.
13. Gupta A., Silver S. Silver as a biocide: will resistance become a problem?. Nat Biotechnol 1998, 16:888.
14. Feng Q.L., Wu J., Chen G.Q., Cui F.Z., Kim T.N., Kim J.O. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res 2000, 52:662-668.
15. Matsumura Y., Yoshikata K., Kunisaki S., Tsuchido T. Mode of bactericidal action of silver zeolite and its comparison with that of silver nitrate. Appl Environ Microbiol 2003, 69:4278-4281.
16. Gupta A., Maynes M., Silver S. Effects of halides on plasmid-mediated silver resistance in Escherichia coli. Appl Environ Microbiol 1998, 64:5042-5045.
17. Hsin Y.H., Chen C.F., Huang S., Shih T.S., Lai P.S., Chueh P.J. The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. Toxicol Lett 2008, 179:130-139.
18. Sondi I., Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci 2004, 275:177-182.
19. Yen H.J., Hsu S.H., Tsai C.L. Cytotoxicity and immunological response of gold and silver nanoparticles of different sizes. Small 2009, 5:1553-1561.
20. Braydich-Stolle L., Hussain S., Schlager J.J., Hofmann M.C. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol Sci 2005, 88:412-419.
21. Hussain S.M., Hess K.L., Gearhart J.M., Geiss K.T., Schlager J.J. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol in Vitro 2005, 19:975-983.
22. Niño-Martínez N., Martínez-Castañón G.A., Aragón-Piña A., Martínez-Gutierrez F., Martínez-Mendoza J.R., Ruiz F. Characterization of silver nanoparticles synthesized on titanium dioxide fine particles. Nanotechnology 2008, 065711:19.
23. Clinical and Laboratory Standards Institute Reference method for broth dilution antifungal susceptibility testing of yeasts; third informational supplement. Approved standard M27-A 1997, CLSI, Wayne (Penn).
24. Clinical and Laboratory Standards Institute Susceptibility testing of mycobacteria, nocardia, and other aerobic actinomycetes 2003, CLSI, Wayne (Penn).
25. Pick N., Cameron S., Arad D., Av-Gay Y. Screening of compounds toxicity against human monocytic cell line-THP-1 by flow cytometry. Biol Proced Online 2004, 6:220-225.
26. Casarett L., Klaassen C.D., Doull J. Casarett and Doull's toxicology: the basic science of poisons 2001, 23-24. McGraw-Hill, New York. C.D. Klaassen (Ed.).
27. Olive P.L., Banath J.P., Durand R.E. Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the ″ comet″ assay. Radiat Res 1990, 122:86-94.
28. Lok C.N., Ho C.M., Chen R., He Q.Y., Yu W.Y., Sun H., et al. Silver nanoparticles: partial oxidation and antibacterial activities. J Biol Inorg Chem 2007, 12:527-534.
29. Morones J.R., Elechiguerra J.L., Camacho A., Ramirez J.T. The bactericidal effect of silver nanoparticles. Nanotechnology 2005, 16:2346-2353.
30. Martínez-Castañón G.A., Niño-Martínez N., Martínez-Gutierrez F., Martínez-Mendoza J.R., Ruiz F. Synthesis and antibacterial activity of silver nanoparticles with different sizes. J Nanoparticle Res 2008, 10:1343-1348.
31. Panacek A., Kvitek L., Prucek R., Kolar M., Vecerova R., Pizurova N., et al. Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity. J Phys Chem 2006, 110:16248-16253.
32. Thiel J., Pakstis L., Buzby S., Raffi M., Ni C., Pochan D.J., et al. Antibacterial properties of silver-doped titania. Small 2007, 3:799-803.
33. 2 nanocomposite powders synthesized by a one-pot sol-gel method. Environ Sci Technol 2009, 43:2905-2910.